Release issued 6th June 2006

York, UK, 24 May 2006—Following the recent re-launch of the Deals and alliances therapy reports, Phamalicensing announces another revised set of reports from the Partneringdesk series in quick succession—the Deals Briefing reports.

Each Deals Briefing report focuses on a top pharmaceutical company, conveniently providing an overview of the deal and alliances announced in the last five years. The report also includes company profile information, consolidated financial data, deal statistics, deal summaries and detailed deal descriptions.

"The Partneringdesk team is continually working on improving and diversifying its range of products to aid biopharmaceutical companies worldwide large or small, in search for potential partners or are interested in deal making activity," said Suzanne Elvidge, Head of Publishing. "Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments."

For more information on Partneringdesk Deals Briefings or other products, go to http://pharmalicensing.com/desk, or contact the Partneringdesk team on tel: +44 1904 520460 or email: partneringdesk@pharmalicensing.com.

(21st May 2007) Bridgehead International wins The Queen's Award for Enterprise

(15th January 2007) New report from Pharmalicensing highlights the R&D opportunities in China

(15th May 2006) Bridgehead International publishes guide to pharma & biotech opportunities in India

(27th April 2006) Pharmalicensing reports on five year therapy area-specific deals and alliances

(27th February 2006) Bridgehead International provides Experts' Report for listing of AGI Therapeutics plc on AIM and IEX